Genetic Factors Affecting Irritable Bowel Syndrome (IBS)

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on Genetics & Digestive Health. Browse all Genetics & Digestive Health education

Irritable bowel syndrome (IBS) affects roughly one in ten people worldwide, causing abdominal pain, bloating, and altered bowel habits without the structural damage seen in other digestive diseases. For years IBS was dismissed as “all in your head.” Modern research tells a different story: IBS is a real disorder of the gut-brain axis, and genetics is part of the picture.

This article explains what IBS is, how it differs from IBD, the role of the gut-brain axis, and the gene variants researchers have connected to the condition.

What IBS is

IBS is a functional gastrointestinal disorder, meaning the gut looks structurally normal but does not work as it should. It is defined by recurrent abdominal pain linked to bowel movements and changes in stool frequency or form. Clinicians classify it by predominant pattern — IBS with diarrhea, IBS with constipation, or a mixed type.

Unlike inflammatory conditions, IBS does not cause the tissue damage, ulceration, or bleeding seen in diseases like Crohn’s or ulcerative colitis. That distinction shapes how it is diagnosed and managed.

IBS versus IBD — a crucial distinction

IBS and inflammatory bowel disease (IBD) are often confused because their names and some symptoms overlap. IBD involves chronic immune-driven inflammation and measurable tissue damage; IBS does not. IBS is a disorder of gut function and gut-brain signaling. Because the two require different evaluation, an accurate diagnosis from a provider matters — alarm symptoms such as bleeding or weight loss always warrant medical review.

The gut-brain axis and serotonin

The gut and brain are in constant two-way communication through nerves, hormones, and immune signals — the gut-brain axis. Serotonin is central here: about 90 percent of the body’s serotonin is produced in the gut, where it regulates motility, secretion, and pain sensitivity. Disruptions in serotonin signaling are a leading explanation for IBS symptoms, which is why the genes controlling serotonin are of such interest.

SLC6A4 and serotonin signaling

The most studied IBS-related gene is SLC6A4, which encodes the serotonin transporter that clears serotonin from the space between nerve cells. A common variation in its promoter region, known as 5-HTTLPR, produces “short” and “long” forms that change how efficiently serotonin is recycled. Variants in SLC6A4 have been associated with IBS and with which bowel pattern predominates in some studies.

The association is not absolute — results vary across populations — but it fits the biology: altered serotonin handling can plausibly change gut motility and pain perception.

Other genes linked to IBS

IBS is polygenic, and several other genes appear in the research. TNFSF15, involved in immune signaling, has shown associations in multiple studies. SCN5A, which encodes a sodium channel affecting gut muscle and nerve activity, has been linked to a subset of cases. Variants in the sucrase-isomaltase (SI) gene, affecting carbohydrate digestion, may contribute to symptoms in some people.

Large genome-wide studies suggest overlap between IBS-related variants and genes influencing mood and anxiety — further evidence for the gut-brain connection.

Managing IBS and where genetics fits

IBS management is individualized and best guided by a provider. Common evidence-based approaches include dietary strategies such as a structured low-FODMAP trial, adequate fiber, regular physical activity, stress management, and sleep. Because the gut-brain axis is central, therapies targeting stress and the nervous system can help some people. There is no one-size-fits-all plan.

Genetic insight adds context, not a cure. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across pathways relevant to serotonin signaling, inflammation, and metabolism. It describes tendencies in your biology — it does not diagnose, treat, or manage IBS. Genetics is a guide, not a guarantee, and any symptoms should be evaluated by a qualified provider.

Frequently Asked Questions

Is IBS genetic?

Partly. IBS is polygenic, with variants in genes such as SLC6A4 (the serotonin transporter), TNFSF15, and SCN5A linked to risk, and it tends to run in families. But genetics is only one contributor — diet, stress, gut microbes, and prior infections also shape whether IBS develops.

What is the difference between IBS and IBD?

IBS is a functional disorder of gut-brain signaling with no structural damage. IBD (Crohn’s and ulcerative colitis) involves chronic immune-driven inflammation and visible tissue injury. They share some symptoms but differ in cause, testing, and treatment. A provider should confirm which condition is present.

How does serotonin relate to IBS?

About 90 percent of the body’s serotonin is made in the gut, where it controls motility, secretion, and pain sensitivity. Altered serotonin signaling — influenced by genes like SLC6A4 — is a leading explanation for IBS symptoms, reflecting the tight two-way link between the gut and the brain.

Can a genetic test diagnose or cure IBS?

No. IBS is diagnosed clinically by a provider based on symptoms and by ruling out other conditions. A genetic test describes pathway-level tendencies in serotonin and inflammation biology; it cannot diagnose, treat, or cure IBS. It offers context about your biology to discuss with a qualified provider.

Curious how your serotonin and inflammation pathways are shaped at the DNA level? Take the Precision Peptide Genetic Test.

This article is part of the PlexusDx Education Hub. Browse all Genetics & Digestive Health education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.